Therapeutic strategies for Parkinson's disease: the ancient meets the future--traditional Chinese herbal medicine, electroacupuncture, gene therapy and stem cells.
In China, it has been estimated that there are more than 2.0 million people suffering from Parkinson's disease, which is currently becoming one of the most common chronic neurodegenerative disorders during recent years. For many years, scientists have struggled to find new therapeutic approaches for this disease. Since 1994, our research group led by Drs. Ji-Sheng Han and Xiao-Min Wang of Neuroscience Research Institute, Peking University has developed several prospective treatment strategies for the disease. These studies cover the traditional Chinese medicine-herbal formula or acupuncture, and modern technologies such as gene therapy or stem cell replacement therapy, and have achieved some original results. It hopes that these data may be beneficial for the research development and for the future clinical utility for treatment of Parkinson's disease.
Wang
Xuan
X
Department of Physiology, Capital Medical University, Key Laboratory for Neurodegenerative Disorders of the Ministry of Education, Beijing, 100069, People's Republic of China.
Liang
Xi-Bin
XB
Li
Feng-Qiao
FQ
Zhou
Hui-Fang
HF
Liu
Xian-Yu
XY
Wang
Jian-Jun
JJ
Wang
Xiao-Min
XM
D000818:Animals; D004224:Diterpenes / Q000627:therapeutic use; D015671:Electroacupuncture; D004852:Epoxy Compounds / Q000627:therapeutic use; D015316:Genetic Therapy; D005968:Glutamate Decarboxylase / Q000235:genetics; D006801:Humans; D008516:Medicine, Chinese Traditional; D010300:Parkinson Disease / Q000628:therapy*; D010616:Phenanthrenes / Q000627:therapeutic use; D033581:Stem Cell Transplantation
D004224:Diterpenes; D004852:Epoxy Compounds; D010616:Phenanthrenes; C001899:triptolide; D005968:Glutamate Decarboxylase